HK Stock MarketDetailed Quotes
06108 NEW RAY MEDIC
- 0.059
- +0.007+13.46%
Market Closed Oct 4 16:08 CST
98.64MMarket Cap-7375P/E (TTM)
0.061High0.052Low14.41MVolume0.054Open0.052Pre Close831.49KTurnover0.86%Turnover RatioLossP/E (Static)1.67BShares0.06952wk High0.21P/B98.64MFloat Cap0.03252wk Low--Dividend TTM1.67BShs Float2.906Historical High--Dividend LFY17.31%Amplitude0.032Historical Low0.057Avg Price8000Lot Size--Div YieldTTM--Div Yield LFY
NEW RAY MEDIC Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 72.17%-22.34M | ---- | -2,125.22%-80.29M | ---- | 94.84%-3.61M | ---- | -59.62%-69.9M | ---- | -211.72%-43.79M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -11.79%-2.97M | ---- | -119.24%-2.66M | ---- | 23.69%-1.21M | ---- | 32.90%-1.59M | ---- | -129.17%-2.37M |
| Interest expense - adjustment | ---- | -81.92%32K | ---- | -36.79%177K | ---- | 154.55%280K | ---- | 111.54%110K | ---- | --52K |
| Dividend (income)- adjustment | ---- | -49.79%-716K | ---- | -449.43%-478K | ---- | 50.00%-87K | ---- | 63.29%-174K | ---- | -172.41%-474K |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | --1.57M | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | 25.20%-1.11M | ---- | 83.98%-1.48M | ---- | 54.19%-9.26M |
| Impairment and provisions: | ---- | -79.82%9.5M | ---- | 911.30%47.06M | ---- | -92.86%4.65M | ---- | 118.17%65.2M | ---- | --29.88M |
| -Impairmen of inventory (reversal) | ---- | -96.23%1.6M | ---- | --42.43M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | -12.05%4.07M | ---- | -0.62%4.62M | ---- | -83.31%4.65M | ---- | 210.76%27.87M | ---- | --8.97M |
| -Other impairments and provisions | ---- | --3.83M | ---- | ---- | ---- | ---- | ---- | 78.47%37.33M | ---- | --20.91M |
| Revaluation surplus: | ---- | ---423K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -85.50%391K |
| -Other fair value changes | ---- | ---423K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -85.50%391K |
| Asset sale loss (gain): | ---- | -27.51%-482K | ---- | -126.53%-378K | ---- | 28,400.00%1.43M | ---- | 102.16%5K | ---- | 98.88%-232K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | --1.42M | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -27.51%-482K | ---- | -7,660.00%-378K | ---- | 0.00%5K | ---- | 102.16%5K | ---- | -2,420.00%-232K |
| Depreciation and amortization: | ---- | -3.99%9.77M | ---- | 5.94%10.17M | ---- | 2.86%9.6M | ---- | -0.46%9.34M | ---- | 16.45%9.38M |
| -Amortization of intangible assets | ---- | -4.92%1.78M | ---- | -3.06%1.87M | ---- | 4.72%1.93M | ---- | 1.99%1.84M | ---- | -3.37%1.81M |
| -Other depreciation and amortization | ---- | -4.92%3.56M | ---- | -3.01%3.74M | ---- | 4.70%3.86M | ---- | 1.99%3.68M | ---- | -14.69%3.61M |
| Special items | ---- | ---- | ---- | --10.39M | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 52.27%-7.64M | ---- | -238.98%-16M | ---- | 666.38%11.51M | ---- | 109.15%1.5M | ---- | -308.92%-16.42M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -95.11%1.98M | ---- | 165.65%40.59M | ---- | -6.45%-61.82M | ---- | -188.45%-58.08M | ---- | 6.86%65.66M |
| Accounts receivable (increase)decrease | ---- | -56.26%-38.8M | ---- | -324.49%-24.83M | ---- | -15.34%11.06M | ---- | 115.24%13.07M | ---- | -269.08%-85.72M |
| Accounts payable increase (decrease) | ---- | -1,484.06%-955K | ---- | 100.36%69K | ---- | -261.05%-19.14M | ---- | 165.03%11.88M | ---- | 67.80%-18.27M |
| Cash from business operations | ---- | -26,453.80%-45.41M | ---- | 99.71%-171K | ---- | -84.62%-58.39M | ---- | 42.24%-31.63M | ---- | -186.58%-54.76M |
| Other taxs | ---- | ---- | ---- | ---147K | ---- | ---- | ---- | 102.82%50K | ---- | 67.12%-1.78M |
| Special items of business | 99.42%-192K | ---- | -290.91%-33.17M | ---- | 135.76%17.37M | ---- | -460.12%-48.59M | ---- | 123.37%13.49M | ---- |
| Net cash from operations | 99.42%-192K | -14,178.93%-45.41M | -290.91%-33.17M | 99.46%-318K | 135.76%17.37M | -84.91%-58.39M | -460.12%-48.59M | 44.15%-31.58M | 123.37%13.49M | -197.72%-56.53M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 11.79%2.97M | ---- | 119.24%2.66M | ---- | -23.69%1.21M | ---- | -32.90%1.59M | ---- | 129.17%2.37M |
| Dividend received - investment | ---- | 40.38%671K | ---- | 449.43%478K | ---- | -50.00%87K | ---- | -63.29%174K | ---- | 172.41%474K |
| Sale of fixed assets | ---- | 26.23%592K | ---- | --469K | ---- | ---- | ---- | -88.46%60K | ---- | 231.21%520K |
| Purchase of fixed assets | ---- | 99.49%-44K | ---- | -14,640.68%-8.7M | ---- | 77.31%-59K | ---- | 77.93%-260K | ---- | 85.60%-1.18M |
| Recovery of cash from investments | ---- | -89.94%3.38M | ---- | -59.63%33.58M | ---- | --83.2M | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | 57.93%-10.72M | ---- | ---25.47M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | -70.17%-14.82M | -104.50%-2.87M | -320.26%-8.71M | -103.00%-1.4M | -92.60%3.95M | 685.51%46.67M | 7,581.61%53.46M | --5.94M | -56.01%696K | ---- |
| Net cash from investment operations | -70.17%-14.82M | -471.63%-6.01M | -320.26%-8.71M | -98.77%1.62M | -92.60%3.95M | 1,647.59%131.1M | 7,581.61%53.46M | 243.97%7.5M | -56.01%696K | 38.04%2.18M |
| Net cash before financing | 64.15%-15.01M | -4,055.38%-51.42M | -296.35%-41.88M | -98.21%1.3M | 337.39%21.33M | 402.05%72.72M | -65.63%4.88M | 55.71%-24.07M | 125.27%14.19M | -191.46%-54.35M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | --11.38M | ---- | ---- | ---- | ---- |
| Refund | ---- | ---- | ---- | ---10.41M | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---- | 81.92%-32K | ---- | 36.79%-177K | ---- | -154.55%-280K | ---- | -111.54%-110K | ---- | ---52K |
| Other items of the financing business | 15.41%-719K | ---- | 93.34%-850K | ---- | -1,429.38%-12.76M | ---- | -11.20%-834K | ---- | -22.15%-750K | ---- |
| Net cash from financing operations | 15.41%-719K | 91.91%-1.01M | 93.34%-850K | -223.84%-12.52M | -1,429.38%-12.76M | 1,090.50%10.11M | -11.20%-834K | -19.14%-1.02M | -22.15%-750K | ---857K |
| Effect of rate | -198.16%-745K | -87.25%1.97M | 111.11%759K | 886.87%15.48M | -506.93%-6.83M | -28.09%1.57M | -45.85%-1.13M | 198.11%2.18M | -207.57%-772K | 36.89%-2.22M |
| Net Cash | 63.18%-15.73M | -367.15%-52.43M | -598.43%-42.73M | -113.55%-11.22M | 112.07%8.57M | 430.06%82.83M | -69.92%4.04M | 54.55%-25.1M | 123.67%13.44M | -192.90%-55.21M |
| Begining period cash | -32.68%103.95M | 2.84%154.41M | 2.84%154.41M | 128.35%150.15M | 128.35%150.15M | -25.84%65.76M | -25.84%65.76M | -39.31%88.67M | -39.31%88.67M | 61.98%146.1M |
| Cash at the end | -22.21%87.48M | -32.68%103.95M | -25.97%112.45M | 2.84%154.41M | 121.19%151.89M | 128.35%150.15M | -32.23%68.67M | -25.84%65.76M | 13.75%101.33M | -39.31%88.67M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
| Auditor | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data